Sign In
Buy EOLS
$6.03
-0.140 (-2.27%)
At Close: Jun 03, 2026
Evolus Announces Appointment of David K. Erickson as Vice President, Investor Relations
09:00am, Wednesday, 30'th Jun 2021
NEWPORT BEACH, Calif., June 30, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (Nasdaq: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today a
Evolus, Inc. (EOLS) CEO David Moatazedi on Q1 2021 Results - Earnings Call Transcript
10:44pm, Wednesday, 12'th May 2021
Evolus, Inc. (EOLS) CEO David Moatazedi on Q1 2021 Results - Earnings Call Transcript
Evolus Reports First Quarter 2021 Results and Provides Business Update
04:05pm, Wednesday, 12'th May 2021
Q1 2021 Net Revenues of $12.2 million, Despite Half-Quarter ITC Impact
Repeat Doses Of Evolus' Frown Lines Treatment Are Safe, With Decreasing Rates Of Adverse Events
10:33am, Wednesday, 12'th May 2021
Evolus Inc (NASDAQ: EOLS) has announced two newly published peer review studies in Aesthetic Surgery Journal that provide supportive evidence of the safety and efficacy of repeat doses of prabotul
Why Evolus (EOLS) Might Surprise This Earnings Season
09:01am, Monday, 10'th May 2021
Evolus (EOLS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Evolus to Report First Quarter 2021 Results and Provide Business Update
04:05pm, Tuesday, 04'th May 2021
NEWPORT BEACH, Calif., May 04, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, announc
Why Evolus Stock Dived by Almost 19% Today
06:02pm, Thursday, 22'nd Apr 2021
Few are smiling about the company's upcoming share issue.
Evolus Announces Pricing of Public Offering of Common Stock
10:30pm, Wednesday, 21'st Apr 2021
NEWPORT BEACH, Calif., April 21, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (Nasdaq: EOLS) announced today the pricing of its public offering of 9,000,000 shares of its common stock at a public offering pr
Evolus Announces Proposed Public Offering of Common Stock
04:01pm, Wednesday, 21'st Apr 2021
NEWPORT BEACH, Calif., April 21, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (Nasdaq: EOLS) announced today that it has commenced a proposed underwritten public offering, subject to market and other conditi
Evolus' (EOLS) CEO David Moatazedi on Q4 2020 Results - Earnings Call Transcript
10:28pm, Wednesday, 24'th Mar 2021
Evolus' (EOLS) CEO David Moatazedi on Q4 2020 Results - Earnings Call Transcript
Evolus, Inc. (EOLS) Reports Q4 Loss, Lags Revenue Estimates
06:17pm, Wednesday, 24'th Mar 2021
Evolus, Inc. (EOLS) delivered earnings and revenue surprises of -231.82% and -0.11%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Evolus Reports Fourth Quarter and Full Year 2020 Results and Provides Business Update
04:05pm, Wednesday, 24'th Mar 2021
Q4 2020 Net Revenue $20.6 Million, Highest Net Revenue Quarter Since Launch of Jeuveau ®
Daewoong Pharmaceutical Injects More Liquidity In Evolus
01:52pm, Tuesday, 23'rd Mar 2021
Evolus Inc (NASDAQ: EOLS) has announced that its strategic partner Daewoong Pharmaceutical Co. Ltd will pay Evolus $25.5 million in cash and eliminate $10.5 million of current and potential futu
Evolus to Report Fourth Quarter and Year End 2020 Results and Provide Business Update
09:21am, Tuesday, 23'rd Mar 2021
NEWPORT BEACH, Calif., March 23, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, annou
Pro Forma Cash Position of $57 Million at December 31, 2020 1
